Participants 213 260 3
patients with bone marrow transplantation (BMT)
Participants 322 345 3
patients undergoing BMT
Participants 385 465 6
66 patients with 43 hematologic and 23 solid malignancies (21 breast carcinomas)
Participants 761 799 4
Patients with hematologic malignancies
Participants 956 996 3
Patients with solid malignancies (n = 23
